Novel therapy delays muscle atrophy in Lou Gehrig’s disease model
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study. Researchers found high levels of the protein — called mitofusion 2 or Mfn2 — prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
Original source: https://www.sciencedaily.com/releases/2018/07/180712123950.htm
